DK3908570T3 - Ketaminpamoat og andevendelse deraf - Google Patents

Ketaminpamoat og andevendelse deraf Download PDF

Info

Publication number
DK3908570T3
DK3908570T3 DK20739053.5T DK20739053T DK3908570T3 DK 3908570 T3 DK3908570 T3 DK 3908570T3 DK 20739053 T DK20739053 T DK 20739053T DK 3908570 T3 DK3908570 T3 DK 3908570T3
Authority
DK
Denmark
Prior art keywords
ketamine pamoate
pamoate
ketamine
Prior art date
Application number
DK20739053.5T
Other languages
English (en)
Inventor
Tong-Ho Lin
Yung-Shun Wen
Chia-Hsien Chen
Wei-Ju Chang
Original Assignee
Alar Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alar Pharmaceuticals Inc filed Critical Alar Pharmaceuticals Inc
Application granted granted Critical
Publication of DK3908570T3 publication Critical patent/DK3908570T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/20Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/34Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
    • C07C211/35Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing only non-condensed rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/105Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic
    • C07C65/11Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic with carboxyl groups on a condensed ring system containing two rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/94Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK20739053.5T 2019-01-11 2020-01-10 Ketaminpamoat og andevendelse deraf DK3908570T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962791058P 2019-01-11 2019-01-11
US201962871763P 2019-07-09 2019-07-09
PCT/CN2020/071404 WO2020143762A1 (en) 2019-01-11 2020-01-10 Ketamine pamoate and use thereof

Publications (1)

Publication Number Publication Date
DK3908570T3 true DK3908570T3 (da) 2024-02-26

Family

ID=71521952

Family Applications (1)

Application Number Title Priority Date Filing Date
DK20739053.5T DK3908570T3 (da) 2019-01-11 2020-01-10 Ketaminpamoat og andevendelse deraf

Country Status (27)

Country Link
US (1) US11981617B2 (da)
EP (1) EP3908570B1 (da)
JP (1) JP7451538B2 (da)
KR (1) KR102892857B1 (da)
CN (1) CN113423686B (da)
AU (1) AU2020206826B2 (da)
CL (1) CL2021001803A1 (da)
CO (1) CO2021006884A2 (da)
DK (1) DK3908570T3 (da)
ES (1) ES2974259T3 (da)
FI (1) FI3908570T3 (da)
HR (1) HRP20240255T1 (da)
HU (1) HUE065684T2 (da)
LT (1) LT3908570T (da)
MX (1) MX2021006029A (da)
MY (1) MY203905A (da)
PE (1) PE20211550A1 (da)
PH (1) PH12021551157A1 (da)
PL (1) PL3908570T3 (da)
PT (1) PT3908570T (da)
RS (1) RS65271B1 (da)
SG (1) SG11202104792SA (da)
SI (1) SI3908570T1 (da)
SM (1) SMT202400100T1 (da)
TW (1) TWI827783B (da)
WO (1) WO2020143762A1 (da)
ZA (1) ZA202103132B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3043785T1 (sl) 2013-09-13 2022-02-28 National University Corporation Chiba University Uporaba R-ketamina in njegove soli kot farmacevtska sredstva
PL3505157T3 (pl) 2017-12-29 2022-04-11 Celon Pharma S.A. Kompozycja ketaminy w postaci suchego proszku do podawania dopłucnego w leczeniu depresji opornej na leczenie
JP7548669B2 (ja) 2018-02-15 2024-09-10 国立大学法人千葉大学 炎症性疾患若しくは骨疾患の予防又は治療剤及び医薬組成物
AU2019262197B2 (en) 2018-05-04 2024-12-19 Perception Neuroscience, Inc. Methods of treating substance abuse
EP4076410B1 (en) * 2019-12-20 2025-09-10 Alar Pharmaceuticals Inc. Long-acting injectable formulations of ketamine pamoate salts
US20210322669A1 (en) * 2020-04-16 2021-10-21 Invictus Health, Inc. Method for treatment of traumatic brain injuries
CN112263572A (zh) * 2020-11-17 2021-01-26 厦门大学附属翔安医院 右旋氯胺酮在制备治疗脱髓鞘疾病药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001051919A2 (en) * 2000-01-07 2001-07-19 Transform Pharmaceuticals, Inc. High-throughput formation, identification, and analysis of diverse solid-forms
US20080293695A1 (en) * 2007-05-22 2008-11-27 David William Bristol Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance
US9421266B2 (en) * 2007-05-22 2016-08-23 Pisgah Laboratories, Inc. Safety of pseudoephedrine drug products
JO2857B1 (en) * 2008-06-16 2015-03-15 سانوفي أفينتس Vinyl pipers with modified activity of tumor-resistant TNF
JO3227B1 (ar) * 2011-09-08 2018-03-08 Otsuka Pharma Co Ltd مشتقات بنزو ثيوفين بها استبدال ببرازين كعوامل مضادة للذهان
JP2014196292A (ja) 2013-03-07 2014-10-16 大塚製薬株式会社 医薬
CN106562952B (zh) * 2015-10-09 2020-06-09 江阴安博生物医药有限公司 氯胺酮在治疗重性抑郁障碍中的应用
WO2017167180A1 (zh) 2016-03-29 2017-10-05 上海华汇拓医药科技有限公司 沃替西汀的帕莫酸盐及其晶型
KR102442753B1 (ko) * 2016-12-26 2022-09-16 셀릭스 바이오 프라이빗 리미티드 만성 통증 치료를 위한 화합물
IL275968B2 (en) * 2018-01-10 2024-07-01 Xwpharma Ltd Prodrugs of ketamine, compositions and uses thereof

Also Published As

Publication number Publication date
ZA202103132B (en) 2024-11-27
EP3908570B1 (en) 2023-12-13
AU2020206826B2 (en) 2024-05-02
SMT202400100T1 (it) 2024-05-14
BR112021013340A2 (pt) 2021-09-14
EP3908570A1 (en) 2021-11-17
JP2022518003A (ja) 2022-03-11
TWI827783B (zh) 2024-01-01
MY203905A (en) 2024-07-24
SI3908570T1 (sl) 2024-04-30
KR20210116517A (ko) 2021-09-27
US20220119338A1 (en) 2022-04-21
RS65271B1 (sr) 2024-03-29
CN113423686B (zh) 2023-08-22
WO2020143762A1 (en) 2020-07-16
PH12021551157A1 (en) 2021-11-03
ES2974259T3 (es) 2024-06-26
CA3118954A1 (en) 2020-07-16
TW202042796A (zh) 2020-12-01
PT3908570T (pt) 2024-03-15
SG11202104792SA (en) 2021-06-29
CL2021001803A1 (es) 2021-12-24
LT3908570T (lt) 2024-03-12
JP7451538B2 (ja) 2024-03-18
US11981617B2 (en) 2024-05-14
FI3908570T3 (fi) 2024-02-13
HRP20240255T1 (hr) 2024-05-24
EP3908570A4 (en) 2022-10-19
PE20211550A1 (es) 2021-08-16
CN113423686A (zh) 2021-09-21
AU2020206826A1 (en) 2021-06-03
MX2021006029A (es) 2021-09-23
NZ775810A (en) 2024-07-26
PL3908570T3 (pl) 2024-07-01
KR102892857B1 (ko) 2025-11-27
CO2021006884A2 (es) 2021-06-10
HUE065684T2 (hu) 2024-06-28

Similar Documents

Publication Publication Date Title
DK3932919T3 (da) Jak-inhibitorforbindelse og anvendelse deraf
IL285178A (en) Compounds and uses thereof
DK3917616T3 (da) Heterocykliske forbindelser og anvendelse deraf
IL280915A (en) Single-chain chimeric polypeptides and uses thereof
DK3870579T3 (da) Tyk2-inhibitorer og anvendelser deraf
DK3908570T3 (da) Ketaminpamoat og andevendelse deraf
DK3784283T3 (da) Cannabidiopræparater og anvendelser deraf
DK3753937T3 (da) Atr-hæmmer og anvendelse deraf
IL285461A (en) Processes and compounds
DK3610005T3 (da) Peptidligase og anvendelse deraf
DK3877052T3 (da) Pyridazinonforbindelser og anvendelser deraf
DK3877376T3 (da) Pyridazinonforbindelser og anvendelser deraf
DK3543240T3 (da) URAT1-inhibitor og anvendelse deraf
DK3621694T3 (da) Lrrc33-inhibitorer og anvendelse heraf
DK3892621T3 (da) Haloallylaminforbindelser og anvendelse deraf
DK4034535T3 (da) Aza-quinolinforbindelser og anvendelser deraf
EP3741758A4 (en) BROMODOMAIN INHIBITOR COMPOUND AND ITS USE
DK4043460T3 (da) Antiproliferationsforbindelser og anvendelser deraf
DK3919498T6 (da) Pyrrolopyrimidinderivat og anvendelse deraf
IL286622A (en) Prmt5 inhibitors and uses thereof
DK3737399T5 (da) Atf5-peptidvarianter og anvendelser deraf
EP4017857A4 (en) METTL 16 INHIBITORS AND THEIR USES
DK3932909T3 (da) Benzoindazolonforbindelse og mellemprodukt heraf
DK3573611T3 (da) Amidforbindelser og anvendelse deraf
DK3983387T3 (da) Sulfonylurinstofderivater og anvendelser deraf